Wasatch Advisors LP Has $68.41 Million Stake in Addus HomeCare Corporation $ADUS

Key Points

• Wasatch Advisors reduced its Addus HomeCare stake by 21.5% in the second quarter, selling 186,899 shares. It still held 680,926 shares worth approximately $68.4 million, representing 3.65% of the company.
• Addus HomeCare reported quarterly earnings of $1.73 per share, beating estimates of $1.70, while revenue rose 8% year over year to $377.4 million.
• Analysts maintain a generally positive outlook, with a consensus “Moderate Buy” rating and an average price target of $130.88, compared with the reported share price of $116.89.

Wasatch Advisors LP lowered its position in shares of Addus HomeCare Corporation (NASDAQ:ADUS - Free Report) by 21.5% during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 680,926 shares of the company's stock after selling 186,899 shares during the quarter. Wasatch Advisors LP owned about 3.65% of Addus HomeCare worth $68,413,000 as of its most recent SEC filing.

Several other hedge funds have also recently made changes to their positions in the business. Global Retirement Partners LLC boosted its position in shares of Addus HomeCare by 395.7% during the 4th quarter. Global Retirement Partners LLC now owns 233 shares of the company's stock valued at $25,000 after purchasing an additional 186 shares in the last quarter. Larson Financial Group LLC increased its holdings in Addus HomeCare by 133.3% in the third quarter. Larson Financial Group LLC now owns 238 shares of the company's stock worth $28,000 after purchasing an additional 136 shares in the last quarter. Acumen Wealth Advisors LLC acquired a new position in Addus HomeCare in the fourth quarter valued at approximately $29,000. Private Trust Co. NA lifted its stake in Addus HomeCare by 65.5% in the fourth quarter. Private Trust Co. NA now owns 283 shares of the company's stock valued at $30,000 after buying an additional 112 shares during the period. Finally, Arax Advisory Partners boosted its holdings in shares of Addus HomeCare by 95.8% during the 4th quarter. Arax Advisory Partners now owns 280 shares of the company's stock worth $30,000 after buying an additional 137 shares in the last quarter. 95.35% of the stock is owned by institutional investors.

Addus HomeCare Price Performance

Shares of ADUS opened at $116.89 on Wednesday. The business's fifty day moving average is $105.21 and its 200 day moving average is $101.81. Addus HomeCare Corporation has a 12-month low of $87.95 and a 12-month high of $124.43. The company has a quick ratio of 1.69, a current ratio of 1.69 and a debt-to-equity ratio of 0.05. The stock has a market cap of $2.18 billion, a P/E ratio of 20.51, a P/E/G ratio of 1.60 and a beta of 0.87.

Addus HomeCare (NASDAQ:ADUS - Get Free Report) last announced its quarterly earnings results on Monday, August 3rd. The company reported $1.73 EPS for the quarter, beating analysts' consensus estimates of $1.70 by $0.03. Addus HomeCare had a net margin of 7.13% and a return on equity of 9.96%. The business had revenue of $377.41 million during the quarter, compared to analyst estimates of $376.24 million. During the same quarter in the previous year, the business posted $1.49 EPS. Addus HomeCare's quarterly revenue was up 8.0% on a year-over-year basis. Sell-side analysts anticipate that Addus HomeCare Corporation will post 6.29 earnings per share for the current fiscal year.

Insider Activity

In related news, insider Heather Brianne Dixon sold 288 shares of the company's stock in a transaction on Monday, June 22nd. The stock was sold at an average price of $93.77, for a total transaction of $27,005.76. Following the completion of the sale, the insider owned 44,371 shares in the company, valued at approximately $4,160,668.67. This represents a 0.64% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold a total of 788 shares of company stock worth $73,506 over the last 90 days. 4.10% of the stock is owned by insiders.

Wall Street Analysts Forecast Growth

Several analysts have recently weighed in on the stock. Barclays lifted their price objective on shares of Addus HomeCare from $92.00 to $96.00 and gave the company an "underweight" rating in a research note on Wednesday, July 8th. Citigroup reaffirmed a "market outperform" rating on shares of Addus HomeCare in a research note on Friday, July 24th. Royal Bank Of Canada upped their price objective on shares of Addus HomeCare from $130.00 to $134.00 and gave the company an "outperform" rating in a report on Wednesday, August 5th. Citizens Jmp reissued a "market outperform" rating and set a $142.00 price objective on shares of Addus HomeCare in a research report on Monday, May 18th. Finally, Weiss Ratings upgraded Addus HomeCare from a "hold (c-)" rating to a "hold (c)" rating in a research note on Thursday, July 9th. One investment analyst has rated the stock with a Strong Buy rating, seven have given a Buy rating, two have assigned a Hold rating and one has issued a Sell rating to the company. According to data from MarketBeat, Addus HomeCare presently has a consensus rating of "Moderate Buy" and a consensus target price of $130.88.

About Addus HomeCare

Addus HomeCare NASDAQ: ADUS is a leading provider of home and community-based care services for elderly, disabled, and medically complex individuals across the United States. Through a network of company-owned and franchise locations, the company delivers a broad spectrum of non-medical personal care and licensed home health services designed to support clients' independence and quality of life.

The company's core offerings include personal care assistance—covering daily living activities, medication reminders, and light housekeeping—and skilled home health services delivered under the supervision of registered nurses and licensed therapists.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source